ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells.
about
Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells.Deficiency of myotubularin-related protein 14 influences body weight, metabolism, and inflammation in an age-dependent manner.C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathway.Expression of Tim4 in Glioma and its Regulatory Role in LN-18 Glioma Cells.Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent MannerActivation of Caspase-9/3 and Inhibition of Epithelial Mesenchymal Transition are Critically Involved in Antitumor Effect of Phytol in Hepatocellular Carcinoma Cells.Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells
P2860
Q35484306-7F4A6FF3-216A-4D6A-BCBB-DA13E07C946FQ35914705-60901677-42C6-44B0-A9A4-D3591D81E5B2Q36393696-AD36B42B-8620-4A1D-8A5E-11A25AEA84BBQ38733769-A6855AB4-C3C2-422C-B33A-432459432A85Q38755678-2419D779-FFCE-465B-B9A7-9220A8D0EC6CQ38805940-6CDADB75-7C1D-4E33-AB3E-1262CC9650DCQ38841816-7186D84F-35C7-4A3C-B89B-64456C136C82Q38884753-2B948C74-C836-4CA5-8D14-71711205CE6AQ52571263-DE1361D0-1A64-4B11-B742-BC8BD151A157Q58706230-F12579A6-739A-4ABE-AE59-47A770E5A5BD
P2860
ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
ABT-263 enhances sorafenib-ind ...... /WAF1)) in human cancer cells.
@en
type
label
ABT-263 enhances sorafenib-ind ...... /WAF1)) in human cancer cells.
@en
prefLabel
ABT-263 enhances sorafenib-ind ...... /WAF1)) in human cancer cells.
@en
P2093
P2860
P356
P1476
ABT-263 enhances sorafenib-ind ...... /WAF1)) in human cancer cells.
@en
P2093
P2860
P304
P356
10.1111/BPH.12659
P407
P577
2014-07-01T00:00:00Z